Click here to find out if $KRFT is a buy hold or sell.
Watching these stocks. $PFE $EMR $RAD $REV
http://www.barchart.com/opinions/stocks/KRFT
LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...
Continue Reading
New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...
Continue Reading
A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...
Continue Reading
Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...
Continue Reading
Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...
Continue Reading
Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...
Continue Reading
Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...
Continue Reading
Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...
Continue Reading
Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...
Continue Reading
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue Reading
Paycor HCM, Inc. Financial Performance Overview Paycor HCM, Inc. (Nasdaq: PYCR) has released its financial results for the first quarter of fiscal year 2025, marking a remarkable performance period. With total revenues reaching $167.5 million, reflecting a robust increase of 17% compared to the prior year, Paycor has established itself as a leader in human capital...
Continue Reading
Nuvia Dental Implant Centers' Innovative Dental Solutions Nuvia Dental Implant Centers is a recognized leader in advanced dental implant solutions. The center is making waves in the dental community with its revolutionary approach to dental implants, delivering permanent teeth in just 24 hours. Recently, Nuvia's impressive capabilities were highlighted in a segment...
Continue Reading
Textron Inc. Experiences a Dip in Q4 Earnings Textron Inc. recently revealed its Q4 financial results, which fell short of what analysts had anticipated. As a consequence, shares dropped by 1.5% in early trading. This aerospace and defense titan reported adjusted earnings per share of $1.34, a slight miss compared to the consensus estimate of $1.35. Furthermore, the...
Continue Reading
Introduction to Vivici's Innovation Vivici, a dynamic Dutch ingredients startup, is redefining the landscape of protein ingredients with the introduction of its innovative Vivitein™ BLG in the US market. This cutting-edge product not only serves as a dairy protein but also utilizes precision fermentation, marking a significant breakthrough in functional and nutritional...
Continue Reading
Understanding the Solid-state LiDAR Market Dynamics The market for solid-state LiDAR technology is rapidly evolving, and it holds a promising future. As industries increasingly recognize the advantages of solid-state LiDAR systems, the market is projected to reach a valuation of USD 3.20 billion by 2030, a substantial increase from USD 0.50 billion in 2025. This...
Continue Reading